121 related articles for article (PubMed ID: 12181482)
1. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts.
Dall' Oglio F; Nasca MR; D'Agata O; Micali G
Sex Transm Infect; 2002 Aug; 78(4):309-10. PubMed ID: 12181482
[No Abstract] [Full Text] [Related]
2. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children.
Micali G; Nasca MR; Tedeschi A; Dall'Oglio F; Pulvirenti N
Pediatr Dermatol; 2000; 17(4):315-8. PubMed ID: 10990585
[TBL] [Abstract][Full Text] [Related]
3. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
[TBL] [Abstract][Full Text] [Related]
4. Squaric acid immunotherapy for warts in children.
Silverberg NB; Lim JK; Paller AS; Mancini AJ
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):803-8. PubMed ID: 10775858
[TBL] [Abstract][Full Text] [Related]
5. Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
Park HJ; Choi YW; Kim SH; Shin MS; Lee SW; Oh MK; Choi HY
Clin Exp Dermatol; 2013 Oct; 38(7):775-81. PubMed ID: 23611147
[TBL] [Abstract][Full Text] [Related]
6. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
Lee AN; Mallory SB
J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial.
DallʼOglio F; Luca M; Barresi S; Micali G
Dermatitis; 2017; 28(5):308-312. PubMed ID: 28885314
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous warts with squaric acid dibutylester: a decade of experience.
Micali G; Dall'Oglio F; Tedeschi A; Pulvirenti N; Nasca MR
Arch Dermatol; 2000 Apr; 136(4):557-8. PubMed ID: 10768664
[No Abstract] [Full Text] [Related]
9. Successful treatment of anal and perianal condyloma acuminata with imiquimod.
Tawada C; Oshitani Y; Kimura M; Seishima M
Acta Derm Venereol; 2014 Jan; 94(1):118-9. PubMed ID: 23824207
[No Abstract] [Full Text] [Related]
10. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
Claudy AL; Roche H
Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
Silverberg JI; Silverberg NB
J Drugs Dermatol; 2012 Oct; 11(10):1228-30. PubMed ID: 23134989
[TBL] [Abstract][Full Text] [Related]
12. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
Iijima S; Otsuka F
Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
[TBL] [Abstract][Full Text] [Related]
13. Difficult wart cases -- use of imiquimod cream 5%.
O'Mahony C
Int J STD AIDS; 2001 Jun; 12(6):400-3. PubMed ID: 11368824
[TBL] [Abstract][Full Text] [Related]
14. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
[TBL] [Abstract][Full Text] [Related]
15. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children.
Pandey S; Wilmer EN; Morrell DS
Pediatr Dermatol; 2015; 32(1):85-90. PubMed ID: 25040421
[TBL] [Abstract][Full Text] [Related]
16. Treatment of warts with contact allergens.
Word AP; Nezafati KA; Cruz PD
Dermatitis; 2015; 26(1):32-7. PubMed ID: 25581668
[TBL] [Abstract][Full Text] [Related]
17. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
18. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
[No Abstract] [Full Text] [Related]
19. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
20. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
